Is Low Level Viremia Acceptable During Antiviral Therapy of Patients With HBV Infection and Decompensated Cirrhosis?

被引：6
|
作者：
Terrault, Norah [1 ]
机构：
[1] Univ Calif San Francisco, Div Gastroenterol Hepatol, San Francisco, CA 94143 USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 16卷 / 12期
关键词：
CHRONIC HEPATITIS-B; HEPATOCELLULAR-CARCINOMA; VIROLOGICAL RESPONSE; ENTECAVIR TREATMENT; NAIVE PATIENTS; METAANALYSIS; ADULTS;
D O I：
10.1016/j.cgh.2018.09.010
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1876 / 1878
页数：3
相关论文
共 50 条
  • [1] Antiviral therapy of patients with decompensated cirrhosis associated with hepatitis C virus infection
    Ji, F. P.
    Deng, H.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S83 - S83
  • [2] Efficacy and safety of lamivudine therapy in patients with decompensated liver cirrhosis caused by HBV infection
    Jung, SA
    Chung, YH
    Yang, SH
    Song, BC
    Lee, SS
    Chang, WY
    Jung, SW
    Hong, IR
    Kim, JY
    Lee, YS
    Suh, DJ
    HEPATOLOGY, 1999, 30 (04) : 645A - 645A
  • [3] Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis
    Huang, Daniel Q. Q.
    Tamaki, Nobuharu
    Lee, Hyung Woong
    Park, Soo Young
    Lee, Yu Rim
    Lee, Hye Won
    Lim, Seng Gee
    Lim, Tae Seop
    Kurosaki, Masayuki
    Marusawa, Hiroyuki
    Mashiba, Toshie
    Kondo, Masahiko
    Uchida, Yasushi
    Kobashi, Haruhiko
    Furuta, Koichiro
    Izumi, Namiki
    Kim, Beom Kyung
    Sinn, Dong Hyun
    HEPATOLOGY, 2023, 77 (05) : 1746 - 1756
  • [4] Safety and efficacy of antiviral therapy in patients with decompensated cirrhosis associated with chronic hepatitis C infection
    Lim, JK
    Imperial, JC
    JOURNAL OF HEPATOLOGY, 2005, 42 : 211 - 211
  • [5] Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis
    Pearlman, Brian L.
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (05) : 1551 - 1561
  • [6] Safety and efficacy of antiviral therapy in patients with decompensated cirrhosis associated with chronic hepatitis C infection
    Lim, JK
    Imperial, JC
    GASTROENTEROLOGY, 2005, 128 (04) : A719 - A719
  • [7] Management of patients with decompensated HBV cirrhosis
    Fontana, RJ
    SEMINARS IN LIVER DISEASE, 2003, 23 (01) : 89 - 100
  • [8] A SYSTEMATIC REVIEW OF ORAL ANTIVIRAL AGENTS IN DECOMPENSATED HBV CIRRHOSIS
    Singal, Ashwani K.
    Fontana, Robert J.
    HEPATOLOGY, 2010, 52 (04) : 506A - 507A
  • [9] Survival Benefit of Direct Acting Antiviral Therapy in Patients with Decompensated Cirrhosis
    Kim, W. Ray
    Mannalithara, Ajitha
    Lee, Hae Won
    Osinusi, Anu O.
    Schall, Raul E. Aguilar
    Brainard, Diana M.
    HEPATOLOGY, 2017, 66 (06) : 1270A - 1271A
  • [10] The impact of HBV flare on the outcome of HBV-related decompensated cirrhosis patients with bacterial infection
    Cao, Zhujun
    Liu, Yuhan
    Wang, Shijin
    Lu, Xiaobo
    Yin, Shan
    Jiang, Shaowen
    Chen, Liuying
    Cai, Minghao
    Zeng, Bo
    Yao, Yujing
    Tang, Weiliang
    Zhao, Gangde
    Xiang, Xiaogang
    Wang, Hui
    Cai, Wei
    Zhu, Chuanwu
    Li, Hai
    Xie, Qing
    LIVER INTERNATIONAL, 2019, 39 (10) : 1943 - 1953
12345